Table 1 Characteristics of diabetic with composite CVD and without composite CVD groups
With composite CVD n = 51 | Without composite CVD n = 49 | P values | |
|---|---|---|---|
Gender no. (%) | |||
Male | 15(29.4%) | 18(36.7%) | 0.436 |
Female | 36(70.6%) | 31(63.3%) | |
Age Mean ± SD | 54.78 ± 5.03 | 52.12 ± 4.96 | 0.009 |
BMI Mean ± SD | 33.14 ± 7.79 | 28.82 ± 5.37 | 0.002 |
Smoking no. (%) | 10(19.6%) | 9(18.4%) | 0.874 |
HTN No. (%) | 28(54.9%) | 22(44.9%) | 0.317 |
Diabetic duration Mean ± SD | 11.15 ± 6.54 | 6.54 ± 3.4 | 0.000 |
Peripheral SBP | 137.12 ± 16.68 | 121.24 ± 13.91 | 0.000 |
Peripheral DBP | 82.18 ± 13.25 | 76.33 ± 11.35 | 0.02 |
Mean peripheral BP | 100.78 ± 12.85 | 90.96 ± 10.59 | 0.000 |
Central SBP | 126.78 ± 16.26 | 112.73 ± 11.63 | 0.000 |
Central DBP | 83.41 ± 13.45 | 76.96 ± 11.35 | 0.011 |
Aix 75 | 26.67 ± 11.57 | 20.57 ± 12.04 | 0.011 |
FBS (mg/dl) | 295.88 ± 84.73 | 172.37 ± 77.19 | 0.000 |
HbA1c (%) | 9.86 ± 1.71 | 6.92 ± 1.34 | 0.000 |
Creatinine (umol/L) | 94.9 ± 57.08 | 88.18 ± 41.61 | 0.504 |
LDL (mg/dl) | 144.37 ± 62.81 | 113.73 ± 28.72 | 0.002 |
TG (mg/dl) | 209.22 ± 77.99 | 165.08 ± 98.36 | 0.014 |
Cholesterol (mg/dl) | 206.65 ± 59.31 | 164.47 ± 47.94 | 0.000 |
Microalbuminuria no. (%) | 14(27.5%) | 5(10.2%) | 0.028 |
Anti-diabetic medication no. (%) | |||
Insulin | 23(45.1%) | 18(36.7%) | 0.395 |
Sulfonylurea | 20(39.2%) | 21(42.9%) | 0.711 |
Metformin | 11(21.6%) | 12(24.5%) | 0.729 |
DPP4I | 5(9.8%) | 2(4.1%) | 0.437 |
SGLT2I | 0(0%) | 3(6.1%) | 0.114 |
HTN medication no. (%) | |||
B-blocker | 15(29.4%) | 5(10.2%) | 0.016 |
Diuretics | 6(11.8%) | 5(10.2%) | 0.803 |
ACEI | 6(11.8%) | 11(22.4%) | 0.155 |
ARBs | 6(11.8%) | 3(6.1%) | 0.488 |
CCB | 4(7.8%) | 4(8.2%) | 1 |
Other medication no. (%) | |||
Aspirin | 26(51%) | 1(2%) | 0.000 |
Statin | 9(17.6%) | 1(2%) | 0.016 |